Animal Study Medical RF · Mice (unspecified number) and 20 human patients · Emerging evidence

Low-Power Short-Pulse-Width Fractional Microneedle Radiofrequency Relieves LL37-Induced Rosacea-Like Skin Inflammation.

Journal of cosmetic dermatology · 2026 02 10
Zhiyi Xu, Siqi Shen, Jingting Zhao et al.

"Medical-grade radiofrequency delivered through microneedles at specific low-power settings can effectively treat rosacea by reducing inflammation and blood vessel formation."

Background

Rosacea is a common skin condition that causes persistent facial redness, visible blood vessels, and inflammation. Traditional treatments often fall short, leading researchers to explore fractional microneedle radiofrequency (FMR) - a cosmetic procedure that uses tiny needles to deliver controlled radiofrequency energy into the skin. This study aimed to determine the optimal power settings and pulse durations for FMR treatment of rosacea. The researchers wanted to understand not just if the treatment worked, but why it worked at the cellular level. They tested various energy levels (1-4 watts) and pulse widths to find the sweet spot that would reduce inflammation without causing harm.

Key Findings

  • Low-power, short-pulse FMR (1-4W at 20ms pulses) significantly reduced redness and inflammation in mice with rosacea-like skin conditions, with visible improvement in erythema area.
  • The treatment reduced infiltration of inflammatory cells including mast cells and CD4+ T cells, which are key players in the rosacea inflammatory cascade.
  • FMR suppressed the NF-κB signaling pathway, a major inflammation controller, and reduced inflammatory cytokines IL-1β, IL-6, and TNF-α.
  • The treatment decreased formation of new blood vessels (angiogenesis) by reducing CD31+ microvessels, addressing the visible blood vessel component of rosacea.
  • In 20 human patients with rosacea, a single FMR session provided significant improvement that lasted at least 3 months, with no serious adverse events reported.

Context

The radiofrequency levels used in this cosmetic treatment (1-4 watts delivered through microneedles for milliseconds) are highly controlled medical applications, completely different from environmental RF exposure from cell phones (0.6-2 watts spread over larger areas) or WiFi routers (typically 0.1 watts).

Significance

This research matters primarily for people considering cosmetic radiofrequency treatments for rosacea or other skin conditions. While not directly related to environmental EMF exposure concerns, it does provide insights into how controlled radiofrequency energy interacts with skin tissue. The study demonstrates that very specific parameters of radiofrequency energy - low power and short pulses - can have therapeutic anti-inflammatory effects rather than harmful ones. This highlights the importance of dose, duration, and delivery method when considering any radiofrequency exposure. For the millions of people suffering from rosacea, this research offers hope for an effective treatment option that works through multiple biological pathways to reduce both the appearance and underlying inflammation of the condition.

Practical Implications

  • If you have rosacea and are considering FMR treatment, ask your dermatologist specifically about low-power, short-pulse settings (1-4W, 20ms) as this study found these parameters most effective.
  • Don't confuse medical radiofrequency treatments with environmental EMF exposure - medical treatments use precise, controlled doses for specific therapeutic effects.
  • Keep a treatment diary if you undergo FMR for rosacea, noting improvements over the 3-month period shown effective in this study.
  • Discuss with your provider about the anti-inflammatory mechanisms shown in this research to understand if you might be a good candidate based on your specific rosacea triggers.
  • Consider that while this study shows promise, it involved only 20 human patients - larger studies may provide more definitive guidance on optimal treatment protocols.
Original Abstract
Refractory rosacea can be effectively treated with fractional microneedle radiofrequency (FMR), but its optimal parameters need confirmation. To explore the optimal parameters of FMR in treating rosacea-like dermatitis and the underlying mechanisms. A rosacea-like dermatitis mouse model was intervened with FMR of varying pulse energy and width. By assessing the severity of erythema and measuring erythema area, optimal parameters of FMR to treat rosacea-like dermatitis in mice were determined. Pathological staining was performed to examine the infiltration of inflammatory cells and CD31+ microvessels. Expression levels of pro-inflammatory factors were detected by qRT-PCR. The involvement of the NF-κB signaling pathway and its downstream mediators (IL-1β, IL-6, TNF-α) in mice treated with low-power short-pulse-width fractional microneedle radiofrequency (LS-FMR) was detected using Western blotting. In a cohort of 20 patients with erythematotelangiectatic rosacea (ETR) and managed by one session of FMR treatment, therapeutic efficacy was assessed by Multispectral skin analysis system at 3 months of follow-up. LS-FMR at energy levels of 1, 2, 3 and 4 W and pulse width of 20 ms alleviated the severity of erythema and narrowed the erythema area in LL37-induced mice. It significantly inhibited the infiltration of mast cells and CD4+ T cells, polarization of CD4+ T cells to Th1/Th17 cells, angiogenesis, the activation of the NF-κB signaling pathway, as well as the expression of downstream inflammatory cytokines (IL-1β, IL-6, TNF-α). In a cohort of 20 ETR patients, just one session of FMR treatment significantly alleviated erythema at 3 months of follow-up, without obvious adverse events. LS-FMR is a promising approach to treat rosacea by suppressing skin immune responses and angiogenesis. Clinical trial number: Not applicable.

This summary was prepared by EMF Radar to make research more accessible. It is not medical advice. Always consult the original publication and qualified professionals for health decisions.